首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1756487

医院获得性感染控制市场（按类型、最终用途、国家和地区）—2024 年至 2032 年行业分析、市场规模、市场份额及预测

Hospital Acquired Infection Control Market, By Type, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2025年05月15日 | 出版商:

AnalystView Market Insights | 英文 388 Pages | 商品交期: 2-3个工作天内

价格

简介目录

报告重点

2024 年医院获得性感染控制市场规模价值为 213.4598 亿美元，2024 年至 2032 年的复合年增长率为 6.80%。

医院获得性感染控制市场-市场动态

提高对医院获得性感染（HAI）的认识

人们对医院内感染风险和后果的认识不断提高，是推动医院内感染控制市场发展的重要因素。医疗专业人员、管理人员和患者越来越了解医院内感染的危害，例如延长住院时间、增加医疗费用以及提高死亡率。这种日益增强的认知促使医疗机构优先考虑感染控制措施，并投资于先进的预防技术。包括世界卫生组织和美国疾病管制与预防中心在内的全球监管机构和卫生组织都发布了严格的指导方针，进一步强调了医院内感染监测和控制的重要性。为此，医院正采用强而有力的感染预防方案，包括使用抗菌表面、消毒设备和数位追踪系统。此外，公共卫生运动和媒体报道也对一般民众进行了教育，从而提高了病人对安全的期望。因此，已开发市场和新兴市场对感染控制解决方案的需求都在不断增长。

医院获得性感染控制市场-关键见解

根据我们的研究分析师，全球医院获得性感染控制市场预计在 2024 年至 2032 年期间的复合年增长率约为 6.80%。

2023 年按类型细分，设备类别占据了市场主导地位。

根据最终用途细分，医院和重症监护病房 (ICU) 在 2023 年创造了最多的收入。

按地区划分，2023年北美是收入最高的地区。

医院获得性感染控制市场-細項分析：

全球医院获得性感染控制市场分为三类：类型、最终用途和地区。

医院获得性感染 (HAI) 控制市场按类型细分为设备、服务和耗材。设备包括灭菌设备、消毒系统和空气净化装置，这些装置对于维持无菌医疗环境至关重要。服务涵盖由专业供应商提供的感染监测、培训和合规性管理。消毒剂、防腐剂、手套、防护服和口罩等耗材是日常使用的，用于防止感染传播。随着对先进消毒技术（例如 UV-C 系统、自动灭菌器和 HEPA 过滤）的投资不断增加，设备将占据市场主导地位。医院和医疗机构优先考虑耐用的基础设施，以确保持续的感染预防，尤其是在重症监护室 (ICU) 和手术室等高风险区域。对长期感染控制解决方案和符合国际安全标准的追求正在加速尖端设备的采用。随着医疗保健系统的现代化，设备预计将因其在综合感染控制策略中的关键作用而占据市场份额的领先地位。

医院获得性感染 (HAI) 控制市场按最终用途分为医院和重症监护病房 (ICU)、门诊手术和诊断中心以及其他，包括长期护理机构和诊所。由于医院和 ICU 入院人数众多、医疗程序复杂且感染传播风险较高，预计它们将占据市场主导地位。 ICU 尤其需要处理免疫功能低下的患者、侵入性设备以及长期住院，使其成为医院获得性感染 (HAI) 的热点。因此，这些病房需要严格的感染控制规程，并持续投资于设备、耗材和专业服务。全院卫生标准、政府法规和认证要求的实施进一步推动了该领域的需求。此外，全球 HAI 负担的不断加重以及降低相关医疗保健成本的需求，使得医院和 ICU 成为感染控制解决方案的主要消费者。

医院获得性感染控制市场-地理洞察

从地理分布来看，医院获得性感染控制市场分布于北美、亚太、拉丁美洲、欧洲、中东和非洲。这些区域进一步根据业务来源国划分。

北美是医院获得性感染 (HAI) 控制市场的主导地区，这得益于先进的医疗基础设施、严格的政府法规以及日益增强的感染控制意识。美国拥有庞大的医疗体系，且医院相关感染的盛行率不断上升，在北美占据最大的市场份额。美国疾病管制与预防中心 (CDC) 和其他监管机构实施严格的感染控制措施，鼓励医院和医疗保健提供者在设备、耗材和服务方面投入大量资金。此外，自动灭菌系统和空气净化装置等先进技术的广泛采用也进一步促进了市场成长。加拿大也发挥着重要作用，致力于透过公共卫生运动和医疗保健现代化来加强感染预防。

欧洲是医院感染控制市场的另一个主导地区，得益于其强大的医疗保健体系和对病人安全的重视。欧盟已推出旨在改善感染预防和降低医院内感染发生率的法规，从而促进了市场成长。德国、英国和法国等国家拥有完善的医疗保健基础设施，并且越来越多地采用先进的感染控制技术，例如紫外线杀菌和抗菌表面涂层。该地区着重维持高医疗保健标准，加之人们对有效感染控制解决方案的认识和需求不断增长，使得欧洲成为市场的关键参与者。此外，欧洲市场受益于医疗保健提供者和感染控制解决方案供应商之间的紧密合作，确保最佳实践已广泛采用。

医院获得性感染控制市场-竞争格局：

医院获得性感染 (HAI) 控制市场的竞争态势由众多老牌企业和专注于先进技术的新进者共同塑造。 3M、Belimed Inc.、Getinge 和 STERIS 等大型公司凭藉全面的感染控制解决方案（包括灭菌系统、消毒剂和个人防护装备 (PPE)）占据市场主导地位。这些公司以注重产品品质、合规性以及为增强产品功能而投入的大量研发力量而闻名。他们还在数位健康解决方案方面投入巨资，以改善感染监测和追踪。此外，W&H 和 Midmark Corporation 等新进业者和创新者正在引入先进的灭菌设备和自动化系统，以提高安全性和效率。例如，市场中的关键参与者 Sterigenics 专注于伽马射线灭菌技术，并在全球扩展其灭菌能力。这种竞争环境促进了创新，并推动了感染控制方案的改进，使医疗保健提供者和患者受益。

介绍
- 按地区分類的细分市场占有率分析
北美洲
- 概述
- 北美医院获得性感染控制关键製造商
- 北美市场规模及预测（按国家/地区）
- 北美市场规模和预测（按类型）
- 北美市场规模及预测（依最终用途）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲医院获得性感染控制主要製造商
- 欧洲市场规模及预测（按国家/地区）
- 欧洲市场规模与预测（按类型）
- 欧洲市场规模及预测（依最终用途）
- 德国
- 法国
- 义大利
- 西班牙
- 英国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区医院感染控制关键製造商
- 亚太市场规模及预测（按国家/地区）
- 亚太市场规模及预测（按类型）
- 亚太市场规模及预测（依最终用途）
- 印度
- 中国
- 韩国
- 日本
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲医院获得性感染控制关键製造商
- 拉丁美洲市场规模及预测（按国家/地区）
- 拉丁美洲市场规模与预测（按类型）
- 拉丁美洲市场规模及预测（依最终用途）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲医院感染控制关键製造商
- 中东和非洲市场规模及预测（按国家/地区）
- 中东和非洲市场规模和预测（按类型）
- 中东和非洲市场规模及预测（按最终用途）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 其余地区

第 10 章：关键供应商分析-医院获得性感染控制产业

竞争仪錶板
公司简介
- 3M
- Belimed Inc.
- O&M Halyards
- Getinge
- ASP (Advanced Sterilization Products Services, Inc.)
- Sterigenics US, LLC - A Sotera Health Company
- MMM Group
- Midmark Corporation
- STERIS
- W&H
- Others

第 11 章：360 度分析师视角

第 12 章：附录

研究方法
参考
缩写
免责声明
联络我们

简介目录

Product Code: ANV5295

REPORT HIGHLIGHT

Hospital Acquired Infection Control Market size was valued at USD 21,345.98 Million in 2024, expanding at a CAGR of 6.80% from 2024 to 2032.

Hospital Acquired Infection (HAI) Control refers to the comprehensive strategies and practices implemented within healthcare facilities to prevent, monitor, and manage infections that patients acquire during their stay in a hospital or clinical setting. These infections typically develop 48 hours or more after admission and are not present or incubating at the time of entry. Effective HAI control involves a combination of strict hygiene protocols, sterilization of medical instruments, appropriate use of personal protective equipment (PPE), antimicrobial stewardship, and staff training. Surveillance systems are also essential to detect outbreaks and track infection trends. Key infections targeted include bloodstream infections, urinary tract infections, pneumonia, and surgical site infections. The aim is to protect both patients and healthcare workers, minimize complications, reduce healthcare costs, and improve patient outcomes. Continuous education, adherence to guidelines such as those from the CDC or WHO, and institutional commitment are critical to ensuring successful infection control in hospitals.

Hospital Acquired Infection Control Market- Market Dynamics

Rising Awareness of Hospital-Acquired Infections (HAIs)

Increasing awareness about the risks and consequences of hospital-acquired infections is a significant driver of the HAI control market. Healthcare professionals, administrators, and patients are becoming more informed about the dangers posed by HAIs, such as prolonged hospital stays, increased healthcare costs, and higher mortality rates. This growing awareness has prompted healthcare facilities to prioritize infection control measures and invest in advanced prevention technologies. Regulatory bodies and health organizations worldwide, including the WHO and CDC, have issued stringent guidelines, further emphasizing the importance of HAI surveillance and control. In response, hospitals are adopting robust infection prevention protocols, including the use of antimicrobial surfaces, sterilization equipment, and digital tracking systems. Additionally, public health campaigns and media coverage have educated the general population, leading to greater patient expectations for safety. As a result, the demand for infection control solutions is expanding across both developed and emerging markets.

HOSPITAL ACQUIRED INFECTION CONTROL Market- Key Insights

According to our research analyst, the global Hospital Acquired Infection Control Market is expected to develop at a CAGR of approximately 6.80% between 2024-2032.

Segmented by Type in 2023, the Equipment category dominated the market.

Based on End Use segmentation, the Hospitals and Intensive Care Units (ICUs) generated the most income in 2023.

Based on region, in 2023, North America was the region with the highest revenue.

Hospital Acquired Infection Control Market- Segmentation Analysis:

The global Hospital Acquired Infection Control market is divided into three categories: type, end use and region.

The Hospital Acquired Infection (HAI) Control market is segmented by type into Equipment, Services, and Consumables. Equipment includes sterilization devices, disinfection systems, and air purification units essential for maintaining a sterile healthcare environment. Services encompass infection surveillance, training, and compliance management offered by specialized providers. Consumables such as disinfectants, antiseptics, gloves, gowns, and masks are used daily to prevent the spread of infections. Equipment is set to dominate the market, driven by increasing investments in advanced disinfection technologies such as UV-C systems, automated sterilizers, and HEPA filtration. Hospitals and healthcare facilities are prioritizing durable infrastructure that ensures consistent infection prevention, especially in high-risk areas like ICUs and operating rooms. The push for long-term infection control solutions and compliance with international safety standards is accelerating the adoption of cutting-edge equipment. As healthcare systems modernize, equipment is expected to lead in market share due to its critical role in comprehensive infection control strategies.

The Hospital Acquired Infection (HAI) Control market is categorized by end-use into Hospitals and Intensive Care Units (ICUs), Ambulatory Surgical and Diagnostic Centres, and Others, which include long-term care facilities and clinics. Hospitals and ICUs are projected to dominate the market due to the high volume of patient admissions, complex medical procedures, and increased risk of infection transmission in these settings. ICUs, in particular, deal with immunocompromised patients, invasive devices, and extended hospital stays, making them hotspots for HAIs. As a result, these units require strict infection control protocols and continuous investment in equipment, consumables, and specialized services. The implementation of hospital-wide hygiene standards, government regulations, and accreditation requirements further drives demand in this segment. Moreover, the rising global burden of HAIs and the need to reduce associated healthcare costs make hospitals and ICUs the leading consumers of infection control solutions.

Hospital Acquired Infection Control Market- Geographical Insights

Geographically, the Hospital Acquired Infection Control Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Hospital Acquired Infection (HAI) Control market, driven by advanced healthcare infrastructure, stringent government regulations, and increasing awareness about infection control. The United States, with its large healthcare system and rising prevalence of healthcare-associated infections, holds the largest market share in the region. The Centers for Disease Control and Prevention (CDC) and other regulatory bodies enforce strict infection control measures, encouraging hospitals and healthcare providers to invest heavily in equipment, consumables, and services. Additionally, the high adoption rate of advanced technologies, such as automated sterilization systems and air purification units, further boosts market growth. Canada also plays a significant role, focusing on enhancing infection prevention through public health campaigns and healthcare modernization.

Europe is another dominant region in the HAI Control market, driven by a strong healthcare system and a focus on patient safety. The European Union has introduced regulations aimed at improving infection prevention and reducing the incidence of hospital-acquired infections, fostering market growth. Countries like Germany, the UK, and France have well-established healthcare infrastructures and are increasingly adopting advanced infection control technologies, such as UV sterilization and antimicrobial surface coatings. The region's emphasis on maintaining high healthcare standards, combined with rising awareness and demand for effective infection control solutions, positions Europe as a key player in the market. Additionally, the European market benefits from strong collaborations between healthcare providers and infection control solution suppliers, ensuring widespread adoption of best practices.

Hospital Acquired Infection Control Market- Competitive Landscape:

The competitive dynamics of the Hospital Acquired Infection (HAI) Control market are shaped by a mix of established players and new entrants focusing on advanced technologies. Major companies like 3M, Belimed Inc., Getinge, and STERIS dominate the market with a comprehensive range of infection control solutions, including sterilization systems, disinfectants, and personal protective equipment (PPE). These companies are known for their emphasis on product quality, regulatory compliance, and robust R&D efforts to enhance product features. They also make significant investments in digital health solutions to improve infection surveillance and tracking. Additionally, new entrants and innovators, such as W&H and Midmark Corporation, are introducing advanced sterilization equipment and automation systems to improve safety and efficiency. For instance, Sterigenics, a key player in the market, focuses on gamma sterilization technology and expanding its sterilization capabilities globally. This competitive environment fosters innovation and drives improvements in infection control protocols, benefiting healthcare providers and patient outcomes.s

Recent Developments:

In September 2023, 3M launched the Clean-Coat Surface Protectant, a coating designed to eliminate up to 99.9% of bacteria and viruses on high-touch surfaces in hospitals. This innovation aims to reduce the risk of cross-contamination in healthcare environments.

In October 2023, Getinge expanded its sterilization capabilities by acquiring Healthmark Industries Co., Inc., strengthening its position in the U.S. infection control market and enhancing its offerings for instrument sterilization and compliance.

In March 2024, W&H introduced the eLog system, a digital logbook that automatically records and saves sterilization cycles and routine tests. This system enhances workflow efficiency while ensuring compliance with sterilization documentation requirements.

In July 2024, Midmark Corporation unveiled its next-generation M11 and M9 steam sterilizers, featuring enhanced durability and integrated capabilities to streamline instrument processing and improve compliance documentation efficiency.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

3M
Belimed Inc.
O&M Halyards
Getinge
ASP (Advanced Sterilization Products Services, Inc.)
Sterigenics U.S., LLC - A Sotera Health Company
MMM Group
Midmark Corporation
STERIS
W&H
Others

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Equipment
Sterilization Equipment
Heat Sterilization Equipment
Low Temperature Sterilization
Radiation Sterilization
Disinfection Equipment
Washer Disinfector
Flusher Disinfector
Endoscopic Reprocessor Systems
Services
Consumables
Disinfectants
Sterilization Consumables

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

Hospitals and Intensive Care Units (ICUs)
Ambulatory Surgical and Diagnostic Centres
Others

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Hospital Acquired Infection Control Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Hospital Acquired Infection Control Market Snippet by Type
- 2.1.2. Hospital Acquired Infection Control Market Snippet by End-Use
- 2.1.3. Hospital Acquired Infection Control Market Snippet by Country
- 2.1.4. Hospital Acquired Infection Control Market Snippet by Region
2.2. Competitive Insights

3. Hospital Acquired Infection Control Key Market Trends

3.1. Hospital Acquired Infection Control Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Hospital Acquired Infection Control Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Hospital Acquired Infection Control Market Opportunities
3.4. Hospital Acquired Infection Control Market Future Trends

4. Hospital Acquired Infection Control Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Hospital Acquired Infection Control Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Hospital Acquired Infection Control Market Landscape

6.1. Hospital Acquired Infection Control Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Hospital Acquired Infection Control Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Equipment
  - 7.1.2.1. Sterilization Equipment
  - 7.1.2.1.1. Heat Sterilization Equipment
  - 7.1.2.1.2. Low Temperature Sterilization
  - 7.1.2.1.3. Radiation Sterilization
  - 7.1.2.2. Disinfection Equipment
  - 7.1.2.2.1. Washer Disinfector
  - 7.1.2.2.2. Flusher Disinfector
  - 7.1.2.2.3. Endoscopic Reprocessor Systems
- 7.1.3. Services
- 7.1.4. Consumables
  - 7.1.4.1. Disinfectants
  - 7.1.4.2. Sterilization Consumables

8. Hospital Acquired Infection Control Market - By End-Use

8.1. Overview
- 8.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
- 8.1.2. Hospitals and Intensive Care Units (ICUs)
- 8.1.3. Ambulatory Surgical and Diagnostic Centres
- 8.1.4. Others

9. Hospital Acquired Infection Control Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Hospital Acquired Infection Control Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Hospital Acquired Infection Control Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.7. France
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.7.4. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.8. Italy
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.8.4. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.9. Spain
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.9.4. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.10. United Kingdom
  - 9.3.10.1. Overview
  - 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.10.4. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.11. Russia
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.11.3. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.12. Netherlands
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.12.3. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.13. Sweden
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.13.3. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.14. Poland
  - 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.14.3. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.3.15. Rest of Europe
  - 9.3.15.1. Overview
  - 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.3.15.4. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Hospital Acquired Infection Control Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.8. South Korea
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.8.4. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.9. Japan
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.9.4. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Hospital Acquired Infection Control Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Hospital Acquired Infection Control Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hospital Acquired Infection Control Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. 3M
- 10.2.2. Belimed Inc.
- 10.2.3. O&M Halyards
- 10.2.4. Getinge
- 10.2.5. ASP (Advanced Sterilization Products Services, Inc.)
- 10.2.6. Sterigenics U.S., LLC - A Sotera Health Company
- 10.2.7. MMM Group
- 10.2.8. Midmark Corporation
- 10.2.9. STERIS
- 10.2.10. W&H
- 10.2.11. Others